+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rabies Drug"

Rabies Treatment - Global Strategic Business Report - Product Thumbnail Image

Rabies Treatment - Global Strategic Business Report

  • Report
  • May 2024
  • 179 Pages
  • Global
From
Global Rabies Treatment Market 2020-2024 - Product Thumbnail Image

Global Rabies Treatment Market 2020-2024

  • Report
  • December 2020
  • 120 Pages
  • Global
From
From
From
Rabies - Pipeline Review, H2 2020 - Product Thumbnail Image

Rabies - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 108 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

The Rabies Drug market is a subset of the biotechnology industry that focuses on the development and production of drugs and treatments for rabies. Rabies is a viral disease that affects the central nervous system and is transmitted through the saliva of infected animals. The market is driven by the need to develop effective treatments and vaccines to prevent the spread of the disease. The market is composed of a variety of companies, including pharmaceutical companies, biotechnology companies, and research institutions. These companies are involved in the development of new treatments and vaccines, as well as the production and distribution of existing treatments and vaccines. Companies in the Rabies Drug market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more